Anna Bucsics
Impact in
- Economics and Econometrics top 5%
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Family Practice top 10%
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 15
- Pharmaceutical Economics and Policy 12
-
- Pharmaceutical Practices and Patient Outcomes 2
- Co-authors
- Brian Godman (7 shared papers)Thomas Burkhardt (7 shared papers)Jutta Piessnegger (3 shared papers)Björn Wettermark (2 shared papers)Wolfgang C. Winkelmayer (6 shared papers)Nina Zimmermann (1 shared paper)Sabine Vogler (1 shared paper)Claudia Habl (1 shared paper)
- Journals
- Frontiers in Pharmacology (3 papers)Health Policy (2 papers)Orphanet Journal of Rare Diseases (2 papers)International Journal of Technology Assessment in Health Care (2 papers)Pharmacoepidemiology and Drug Safety (2 papers)
- Partner nations
- AustriaUnited KingdomSweden
In The Last Decade
Anna Bucsics
30 papers receiving 560 citations
Peers
Comparison fields: 5 of 71
- Economics and Econometrics 305
- Family Practice 17
- Geriatrics and Gerontology 28
- Pharmacology 61
- Applied Microbiology and Biotechnology 11
Countries citing papers authored by Anna Bucsics
This map shows the geographic impact of Anna Bucsics's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bucsics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bucsics more than expected).
Fields of papers citing papers by Anna Bucsics
This network shows the impact of papers produced by Anna Bucsics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bucsics. The network helps show where Anna Bucsics may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Bucsics, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discounts and rebates granted to public payers for medicines in European countries. | 2012 | 60 |
| 2 | 2008 | 55 | |
| 3 | 2017 | 54 | |
| 4 | 2009 | 50 | |
| 5 | 2018 | 45 | |
| 6 | 2014 | 36 | |
| 7 | 2019 | 32 | |
| 8 | 2014 | 28 | |
| 9 | 2020 | 26 | |
| 10 | 2010 | 25 | |
| 11 | 2011 | 20 | |
| 12 | 2014 | 20 | |
| 13 | 2015 | 20 | |
| 14 | 2013 | 16 | |
| 15 | 2012 | 16 | |
| 16 | 2012 | 14 | |
| 17 | 2007 | 14 | |
| 18 | 2010 | 12 | |
| 19 | 2010 | 10 | |
| 20 | 2015 | 10 |
About Anna Bucsics
Anna Bucsics is a scholar working on Economics and Econometrics, Geriatrics and Gerontology, Pharmacology, Immunology and Surgery, having authored 30 papers that have together received 596 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (12 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Pharmaceutical industry and healthcare (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Acute Myocardial Infarction Research (1 paper), Medication Adherence and Compliance (1 paper) and Diabetes Treatment and Management (1 paper). The work is most often cited by research in Economics and Econometrics (305 citations), Family Practice (17 citations), Geriatrics and Gerontology (28 citations), Pharmacology (61 citations) and Applied Microbiology and Biotechnology (11 citations). Anna Bucsics has collaborated with scholars based in Austria, United Kingdom and Sweden. Frequent co-authors include Brian Godman, Thomas Burkhardt, Jutta Piessnegger, Björn Wettermark, Wolfgang C. Winkelmayer, Nina Zimmermann, Sabine Vogler, Claudia Habl, Berthold Reichardt and Lieven Annemans. Their work appears in journals such as Frontiers in Pharmacology, Health Policy, Orphanet Journal of Rare Diseases, International Journal of Technology Assessment in Health Care and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.